Fisher & Paykel Healthcare Management
Management criteria checks 3/4
Fisher & Paykel Healthcare's CEO is Lewis Gradon, appointed in Apr 2016, has a tenure of 8.58 years. total yearly compensation is NZ$3.53M, comprised of 50.6% salary and 49.4% bonuses, including company stock and options. directly owns 0.098% of the company’s shares, worth NZ$22.51M. The average tenure of the management team and the board of directors is 3.5 years and 4.5 years respectively.
Key information
Lewis Gradon
Chief executive officer
NZ$3.5m
Total compensation
| CEO salary percentage | 50.6% |
| CEO tenure | 8.6yrs |
| CEO ownership | 0.1% |
| Management average tenure | 3.5yrs |
| Board average tenure | 4.5yrs |
Recent management updates
Recent updates
The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence
Oct 28
Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon
Oct 08Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns
Aug 21Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jul 29Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends
Jul 11Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected
Jun 22There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings
Jun 05Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 27Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Feb 22Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price
Feb 05Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 03We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt
Nov 30Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital
Nov 12Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Aug 28Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Aug 10Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly
Jul 02Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
May 01Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)
Jan 23Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Dec 27Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Oct 28Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value
Oct 13Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet
Sep 28Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Jul 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
Jul 10Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly
Jun 12A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Apr 17Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger
Apr 04Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Mar 06With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting
Jan 22Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention
Dec 26Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Dec 05This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation
Aug 11Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?
Aug 01Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?
Jul 07Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jun 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | NZ$4m | NZ$2m | NZ$133m |
| Dec 31 2023 | n/a | n/a | NZ$197m |
| Sep 30 2023 | n/a | n/a | NZ$262m |
| Jun 30 2023 | n/a | n/a | NZ$256m |
| Mar 31 2023 | NZ$3m | NZ$2m | NZ$250m |
| Dec 31 2022 | n/a | n/a | NZ$251m |
| Sep 30 2022 | n/a | n/a | NZ$251m |
| Jun 30 2022 | n/a | n/a | NZ$314m |
| Mar 31 2022 | NZ$4m | NZ$2m | NZ$377m |
| Dec 31 2021 | n/a | n/a | NZ$449m |
| Sep 30 2021 | n/a | n/a | NZ$521m |
| Jun 30 2021 | n/a | n/a | NZ$522m |
| Mar 31 2021 | NZ$4m | NZ$2m | NZ$524m |
| Dec 31 2020 | n/a | n/a | NZ$458m |
| Sep 30 2020 | n/a | n/a | NZ$392m |
| Jun 30 2020 | n/a | n/a | NZ$339m |
| Mar 31 2020 | NZ$3m | NZ$1m | NZ$287m |
| Dec 31 2019 | n/a | n/a | NZ$260m |
| Sep 30 2019 | n/a | n/a | NZ$233m |
| Jun 30 2019 | n/a | n/a | NZ$221m |
| Mar 31 2019 | NZ$3m | NZ$1m | NZ$209m |
| Dec 31 2018 | n/a | n/a | NZ$208m |
| Sep 30 2018 | n/a | n/a | NZ$206m |
| Jun 30 2018 | n/a | n/a | NZ$198m |
| Mar 31 2018 | NZ$2m | NZ$993k | NZ$190m |
Compensation vs Market: Lewis's total compensation ($USD2.07M) is below average for companies of similar size in the NZ market ($USD4.36M).
Compensation vs Earnings: Lewis's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Lewis Gradon (63 yo)
8.6yrs
Tenure
NZ$3,533,971
Compensation
Mr. Lewis G. Gradon has been the Chief Executive Officer, Managing Director & Executive Director at Fisher & Paykel Healthcare Corporation Limited since April 1, 2016. He served as the Senior Vice Presiden...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8.6yrs | NZ$3.53m | 0.098% NZ$ 22.5m | |
| Chief Financial Officer | 5.7yrs | no data | 0.0045% NZ$ 1.0m | |
| COO & GM of Respiratory Humidification | less than a year | no data | 0.00060% NZ$ 137.9k | |
| Vice President of Products & Technology | 8.6yrs | no data | 0.019% NZ$ 4.3m | |
| Head of Capital Markets & Investor Relations | no data | no data | no data | |
| Company Secretary & General Counsel | less than a year | no data | no data | |
| Senior Communications & Investor Relations Manager | no data | no data | no data | |
| VP of Sales & Marketing and President of North America & Europe | less than a year | no data | 0.029% NZ$ 6.6m | |
| Vice President of Human Resources | 4.1yrs | no data | no data | |
| Vice President of Supply Chain | 2.8yrs | no data | no data | |
| Vice President of Corporate | no data | no data | no data | |
| General Manager of Airvo Optiflow | no data | no data | no data |
3.5yrs
Average Tenure
Experienced Management: FPH's management team is considered experienced (3.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8.6yrs | NZ$3.53m | 0.098% NZ$ 22.5m | |
| Non-Executive Director | 23yrs | NZ$188.15k | 0.15% NZ$ 35.3m | |
| Independent Chairman of the Board | 6yrs | NZ$220.74k | 0.0013% NZ$ 291.9k | |
| Independent Non-Executive Director | 3.1yrs | NZ$212.77k | 0.0023% NZ$ 530.9k | |
| Member of EcoDesign Advisory Board | no data | no data | no data | |
| Non-Executive Director | less than a year | no data | no data | |
| Non-Executive Independent Director | 1.1yrs | NZ$93.48k | 0.00032% NZ$ 73.5k | |
| Independent Non-Executive Director | 7.4yrs | NZ$179.08k | 0.00065% NZ$ 149.4k | |
| Independent Non-Executive Director | 2.4yrs | NZ$160.13k | 0.00033% NZ$ 75.8k | |
| Member of EcoDesign Advisory Board | no data | no data | no data | |
| Member of EcoDesign Advisory Board | no data | no data | no data | |
| Member of EcoDesign Advisory Board | no data | no data | no data |
4.5yrs
Average Tenure
63yo
Average Age
Experienced Board: FPH's board of directors are considered experienced (4.5 years average tenure).